Key result
The 2013 European Heart Journal - Cardiovascular Imaging review highlights key advancements in multi-modality imaging for valvular heart disease, heart failure, cardiomyopathies, and congenital heart diseases.
Why the study?
To highlight the most important cardiovascular imaging studies published in the European Heart Journal - Cardiovascular Imaging in 2019, focusing on valvular heart disease, heart failure, cardiomyopathies, and congenital heart disease.
This review highlights the most important multimodality cardiovascular imaging studies published in the European Heart Journal - Cardiovascular Imaging in 2013.
Journal's rise affirms imaging centrality in CV care; leaves open which 2019 findings will alter practice.
The European Heart Journal - Cardiovascular Imaging was launched in 2012 and has during these years become one of the leading multimodality cardiovascular imaging journal. The journal is now established as one of the top cardiovascular journals and is the most important cardiovascular imaging journal in Europe. The most important studies published in our Journal from 2019 will be highlighted in two reports. Part II will focus on valvular heart disease, heart failure, cardiomyopathies, and congenital heart disease. While Part I of the review has focused on studies about myocardial function and risk prediction, myocardial ischaemia, and emerging techniques in cardiovascular imaging.
No takes yet. Share an insight, caveat, or question.
Cosyns et al. (2020) conducted a review in Cardiovascular diseases (valvular heart disease, heart failure, cardiomyopathies, congenital heart diseases). The 2013 European Heart Journal - Cardiovascular Imaging review highlights key advancements in multi-modality imaging for valvular heart disease, heart failure, cardiomyopathies, and congenital heart diseases.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: